Investment Visual

ASND

Ascendis Pharma A/S

Stock

$227.87+0.56 (+0.25%)Close Oct 2, 2026

Selling, general and administrative, 2025: €458M
YoY, 2025: +57.3%
5-year CAGR: +43.0%
10-year CAGR: +47.5%

Selling, general and administrative

Selling, general and administrative by fiscal year

Period	Ended	SG&A	YoY	Filing
2025	Dec 31, 2025	€458M	+57.3%	20-F, Feb 11, 2026
2024	Dec 31, 2024	€291M	+10.1%	20-F, Feb 12, 2025
2023	Dec 31, 2023	€264M	+19.5%	20-F, Feb 7, 2024
2022	Dec 31, 2022	€221M	+38.1%	20-F, Feb 16, 2023
2021	Dec 31, 2021	€160M	+108.9%	20-F, Mar 2, 2022
2020	Dec 31, 2020	€77M	+58.2%	20-F, Mar 10, 2021
2019	Dec 31, 2019	€48M	+93.5%	20-F, Apr 3, 2020
2018	Dec 31, 2018	€25M	+85.9%	20-F, Apr 3, 2019
2017	Dec 31, 2017	€13M	+17.2%	20-F, Mar 28, 2018
2016	Dec 31, 2016	€12M	+22.2%	20-F, Mar 28, 2018
2015	Dec 31, 2015	€9.4M	—	20-F, Mar 28, 2018